Is blockade of vascular endothelial growth factor beneficial for all types of diabetic retinopathy?

Diabetologia. 2008 Sep;51(9):1570-3. doi: 10.1007/s00125-008-1078-9. Epub 2008 Jul 8.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Diabetic Retinopathy / prevention & control*
  • Humans
  • Macular Degeneration / prevention & control
  • Ranibizumab
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Vascular Endothelial Growth Factor A
  • Ranibizumab